Overview & Introduction
Melanie Davies, Chair
As cancer treatments continue to improve, the prospect of long-term survival and cure is becoming ever more a reality. Infertility is the commonest long-term adverse effect of cancer treatment. Consequently fertility preservation in cancer survivors is becoming an increasingly important aspect of our daily clinical practice. This study day will address this important area crossing the boundaries between the various disciplines involved, with talks from Clinicians, Nurses and Scientists both in the fields of Reproductive Medicine and Oncology. The course will cover the effect of cancer treatment on fertility, approaches for male and female fertility preservation, as well as the ins and outs of setting up and managing an effective fertility preservation programme.
15 June 2020
| Time | Session | Speaker |
|---|---|---|
| 08:50 – 09:00 | Welcome | |
| 09:00 – 09:30 | Cancer in young people, long term outcomes | Vicky Grandage |
| 09:30 – 10:00 | The effect of cancer treatment on male fertility and sperm banking | |
| 10:00 – 10:30 | The effect of cancer treatment on female fertility and an overview of female fertility preservation | Richard Anderson |
| 11:00 – 11:30 | Oocyte cryopreservation | Gillian Lockwood |
| 11:30 – 12:00 | Ovarian tissue preservation | Sheila Lane |
| 12:00 – 12:30 | Ovarian transposition for fertility preservation. | Ertan Sardogan |
| 13:30 – 14:00 | The decision making process for women considering fertility preservation | Georgina Jones |
| 14:00 – 14:30 | Ovarian stimulation for oocyte cryopreservation. | Yuliya Kopeika |
| 14:30 – 15:00 | Uterine transplantation | Ben Jones |
| 15:30 – 16:00 | Clinical experience of a fertility preservation service- analysis of outcomes | Stuart Lavery |
| 16:00 – 16:45 | Late effects of cancer treatment: early menopause and the use of HRT | Melanie Davies |
| 16:45 – | Close |